Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at TPC's multiple
$0.7980.3% below market
0.94 ZNTL revenue / share×0.84x TPC P/S=$0.79
Market $3.99Implied $0.79
TPC · current priceP/S 0.84x
$88.21Latest market snapshot
Implied fair value · at ZNTL's multiple
$447.22407.0% above market
105.44 TPC revenue / share×4.24x ZNTL P/S=$447.22
Market $88.21Implied $447.22